Biofrontera (BFRI) Current Assets (2020 - 2025)

Biofrontera's Current Assets history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• On a quarterly basis, Current Assets fell 12.64% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 12.64% decrease from a year earlier, with the FY2025 full-year figure at $18.1 million, down 12.64% from the prior year.
• Current Assets climbed to $18.1 million in Q4 2025 per BFRI's latest filing, from $14.4 million in the prior quarter.
• Across five years, Current Assets topped out at $48.5 million in Q3 2022 and bottomed at $10.1 million in Q3 2021.
• The 5-year median for Current Assets is $20.7 million (2024), against an average of $27.6 million.
• Across the five-year window, Current Assets jumped 378.38% in 2022 and slumped 46.51% in 2023, its largest moves.
• Year by year, Current Assets stood at $46.4 million in 2021, then dropped by 7.07% to $43.1 million in 2022, then slumped by 46.51% to $23.1 million in 2023, then retreated by 10.29% to $20.7 million in 2024, then dropped by 12.64% to $18.1 million in 2025.
• Per Business Quant, the three latest BFRI Current Assets figures stand at $18.1 million (Q4 2025), $14.4 million (Q3 2025), and $18.8 million (Q2 2025).